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Abstract 
A 47 year old Saudi male, presented to hospital* with the chief complaint of skin rash over the buttocks and 
lower limbs of one day duration. The rash followed steroids treatment to treat local allergic reaction to hair dye. 
The patient was quite well before that and his medical history, examination and laboratory investigation 
revealed nothing of concern. After admission, the skin rash had progressed to multiform rash and pustules 
following administration of methyl prednisolone 40 mg intravenously.  The patient’s condition progressed and 
he developed gastrointestinal symptoms. The patient eventually started to respond to medical management and 
was discharged in better health but he was readmitted after two days with the same skin rash due to the wearing 
off of the effect of infliximab injection. A second dose of infliximab injection was given and his condition 
improved.  
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1. Introduction 
Reactions to one hair- dye product or another after use are not that uncommon. They range from irritation 
occurring locally in areas in direct contact with dye (irritant contact dermatitis) to genuine allergy, which will 
provoke local symptoms (allergic contact dermatitis). It may also produce a systemic reaction affecting other 
areas of the body. In both cases, the symptoms can vary from very mild to quite severe. The local irritation will 
tend to affect the scalp, neck, forehead, ears and eyelids. The generalized symptoms may include more 
widespread itching, or rarely, anaphylaxis. 
The vast majority of cases of small vessel vacuities follow acute infection (1)or administration of new 
medication (2)but it is very rare if any to see small vessel vasculitis (henoch-schonlein purpura) (4,5 ) secondary 
to steroids. 
The aim of reporting this case is to shed lights on the provoking effect caused by administering corticosteroids 
to treat hair dye allergic reactions. 
2. Materials and Methods 
A 47 year old Saudi male, presented at our hospital* with the chief complaint of skin rash over the buttocks and 
lower limbs of one day duration. 
The patient was quite well, not known to have any medical problem. Six days prior to his presentation he visited 
his barbershop where he had hair dye applied to his hair, beard and moustache.  The next day he developed 
burning sensation, redness and swelling of the skin of his face.  He sought medical advice where he was 
prescribed prednisolone 30 mg tablets daily for five days. On the 6th day, he developed the skin rash. He had no 
other complaint and his systematic review was unremarkable. 
He gave no history of other drugs taken at the time nor having similar attacks before.  His family history was 
irrelevant. 
On examination, his general condition was fair, vitally stable, not febrile, no joint swelling, no palpable lymph 
nodes. The rash was purpuric which involved the buttocks and lower extremities with mild scattered rash on the 
chest and the abdomen (Figure 1). The other systemic examination was unremarkable.  
The patient was admitted to the hospital, he was given methyl prednisolone 40 mg intravenously. The next day 
the skin rash had progressed to multiform rash and started to develop vesicles and bullae, more on the lower 
limbs (Figure 2). So, prednisolone was discontinued but in spite of that the rash continued to progress to 
pustules.  
3. Results 
The initial routine investigations were all within normal limits, but repeated lab results showed: 
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• CBC:  WBC elevated to 33000, the Hgb dropped from 16g/dl to 11 g/dl, the PLT increased to more 
than 700,000. 
• His inflammatory marker increased: CRP 20, ESR 50. 
 
Figure 1: Scattered purpuric rash on the patient’s chest and abdomen (2) 
 
Figure 2: Multi form rash in the patient’s lower limbs 
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Figure 3: Colonoscopy findings of the patient 
Arrow:  Rectal polyp (incidental finding) 
4. Conclusions 
Following the deterioration of the patient’s condition and new laboratory findings he was given empirical 
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parenteral antibiotics. 
The dermatologist was consulted, evaluated the patient, skin biopsy taken, and he prescribed topical potassium 
permanganate and Fusicort skin ointment. 
However, the rash was more progressive, for that the Fusicort was changed to plain Fusidic Acid skin ointment 
aiming to avoid steroids. The patient was started on Mycofenalate tablets and intravenous immunoglobulin 
infusions. He then started to develop gastro- intestinal symptoms in the form of nausea, abdominal pain and 
bloody diarrhea.  
The patient underwent colonoscopy examination, which showed vasculitic changes (Figure 3). The Patient 
received infliximab injection then he was kept NPO (nil per oral) and started on (TPN)total parental nutrition.  
After two weeks of total parental nutrition he was gradually started on oral intake after his gastro intestinal 
symptoms subsided. His skin rash started to improve gradually, his general condition was improving. His 
condition improved and he was discharged home in stable condition. His skin biopsy showed 
leukocytoclastic vasculitis. 
The Patient was re-admitted after two days with the same skin rash. Since infliximab injection effect covers only 
two weeks, a second dose of infliximab injection was given. His skin rash improved and he was discharged 
home on mycofenolate tablets for 7 days and Vancomycine 250 mg for 10 days since bowel sepsis was 
suspected. 
Fortunately the patient did not develop serious complications like pyelonephritis(2) or pulmonary hemorrhage 
(3). 
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